CenExel Marlton, NJ
- 401 Route 73 N | 30 Lake Center Executive Park, #100
- Marlton,
- 8753
- 833-427-7626
Opioid addiction, or opioid use disorder (OUD), is marked by a powerful, compulsive desire to use opioid drugs, even when they are no longer needed for medical reasons. This condition can lead to both physical and psychological dependence, making it challenging for individuals to quit using opioids, despite the harmful effects on their health, relationships, and everyday life.
Intense cravings for opioids
Increased tolerance (requiring more of the drug for the same effect)
Withdrawal symptoms when not using (e.g., sweating, shaking, nausea)
Difficulty controlling or reducing opioid use
Engaging in risky behaviors to obtain opioids (e.g., doctor shopping, illegal activities)
Changes in appearance (e.g., weight loss, neglect of personal hygiene)
Social withdrawal or isolation
Mood swings or irritability
Reduced interest in activities once enjoyed
Continued use despite negative health or personal consequences
Studies are currently available for qualified participants.
Opioid addiction, or opioid use disorder (OUD), is marked by a powerful, compulsive desire to use opioid drugs, even when they are no longer needed for medical reasons. This condition can lead to both physical and psychological dependence, making it challenging for individuals to quit using opioids, despite the harmful effects on their health, relationships, and everyday life.
Intense cravings for opioids
Increased tolerance (requiring more of the drug for the same effect)
Withdrawal symptoms when not using (e.g., sweating, shaking, nausea)
Difficulty controlling or reducing opioid use
Engaging in risky behaviors to obtain opioids (e.g., doctor shopping, illegal activities)
Changes in appearance (e.g., weight loss, neglect of personal hygiene)
Social withdrawal or isolation
Mood swings or irritability
Reduced interest in activities once enjoyed
Continued use despite negative health or personal consequences
Studies are currently available for qualified participants.
We have helped tens of thousands of patients in similar clinical trials. Space in this study is limited. To be considered, fill out the interest form.
State-of-the-art Facilities
Our award-winning Centers are held to the highest quality standards in medical equipment technology, cleanliness, and comfort.
Board-certified Physicians
Our medical staff and professional researchers are seasoned experts in their areas of expertise and the clinical trial field.
Safe, Approved Procedures
Clinical research methods undergo rigorous evaluation and scrutiny, similar to the standards at any other hospital or clinic.
CenExel Centers of Excellence are leaders in the clinical trial world, improving lives through new and better medicines. Our Centers prioritize quality of care and participant safety. Our Principal Investigator physicians are board-certified medical research experts, and our professional support staff is highly experienced as well. We regularly revisit training and best practices to ensure first-class care. CenExel state-of-the-art facilities are spacious, comfortable, and appropriately private.
While the clinical study process varies for each trial, there are certain steps that regularly occur. Before you begin a study, all procedures and details will be thoroughly explained to you. Over the course of the study, the Study Coordinator and Principal Investigator physician will assist you and answer questions. They will check your health at the beginning of the trial, give you specific instructions for participating, monitor you carefully during the trial, and stay in touch with you after the study.
Some clinical trials involve more tests and doctor visits than you would normally have for your illness or condition. Your participation will be most successful if you carefully follow all instructions you are given and stay in contact with the research staff.
There are many safeguards in place that all research organizations must follow when conducting clinical trials. At CenExel, we proudly adhere to these safeguards and take additional steps to ensure participant safety and comfort.
The Food and Drug Administration (FDA) is the regulatory agency that oversees all clinical research conducted in the United States. It is their responsibility to protect the rights and, as much as possible, the welfare of subjects participating in clinical trials. The FDA reviews the data collected from clinical trials because they ultimately determine whether a new treatment should be sold in the U.S. Several organizations and individuals are governed by FDA regulations including clinical investigators, pharmaceutical sponsors (the companies developing the treatments), Contract Research Organizations (companies that help conduct the studies), and Institutional Review Boards (groups that are responsible for ensuring the safety and welfare of study participants).
Good Clinical Practice (GCP) guidelines are industry guidelines designed to protect the safety of trial subjects. These guidelines encompass federal regulations and industry-accepted standards that govern clinical trials. These regulations and standards apply to the conduct of the studies, record keeping, informed consent of subjects, collection of scientific data, and submission of information needed for the FDA to determine whether a new treatment should be sold in the U.S. All research organizations must follow these guidelines when conducting clinical research.
An Institutional Review Board (IRB) is a committee that is formally tasked by an institution to review, approve, and monitor research involving human subjects. IRBs ensure that the risks to subjects are minimized; that subjects are adequately informed about the trial and the implications it will have on their treatment; that study protocols are modified, when necessary, to ensure safety; that risks are reasonable in relation to the anticipated benefits and the importance of the knowledge to be gained; that subject selection is equitable and that no classes of patients are discriminated against; that informed consent is obtained; that there is a provision for safety monitoring in the research plan; and that there are adequate provisions for the privacy and confidentiality for subjects and the data collected.